{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:18:38Z","timestamp":1788866318453,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002608","name":"American Thyroid Association","doi-asserted-by":"publisher","award":["THYROIDGRANT2021-0000000232"],"award-info":[{"award-number":["THYROIDGRANT2021-0000000232"]}],"id":[{"id":"10.13039\/100002608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002608","name":"American Thyroid Association","doi-asserted-by":"publisher","award":["2023-449"],"award-info":[{"award-number":["2023-449"]}],"id":[{"id":"10.13039\/100002608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.eprac.2024.01.001","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T04:16:30Z","timestamp":1704428190000},"page":"311-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Survival Outcomes of Medullary Thyroid Cancer With and Without Amyloid Deposition"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9267-3787","authenticated-orcid":false,"given":"Eman","family":"Toraih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Baah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Pinion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3436-8889","authenticated-orcid":false,"given":"Jessan","family":"Jishu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salmanfaizee","family":"Sadakkadulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"LaForteza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Moroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Kandil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.eprac.2024.01.001_bib1","doi-asserted-by":"crossref","first-page":"lvac009","DOI":"10.1093\/ejendo\/lvac009","article-title":"Other markers of medullary thyroid cancer, not only calcitonin","volume":"188","author":"Censi","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2024.01.001_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/20420188211049611","article-title":"Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis","volume":"12","author":"Bartz-Kurycki","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2024.01.001_bib3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2174\/138920211798120835","article-title":"Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers","volume":"12","author":"Taccaliti","year":"2011","journal-title":"Curr Genomics"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.eprac.2024.01.001_bib4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.14639\/0392-100X-suppl.1-40-2020","article-title":"Metastatic disease in head & neck oncology","volume":"40","author":"Pisani","year":"2020","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"6","key":"10.1016\/j.eprac.2024.01.001_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clon.2010.05.002","article-title":"Medullary thyroid carcinoma","volume":"22","author":"Pacini","year":"2010","journal-title":"Clin Oncol"},{"issue":"9","key":"10.1016\/j.eprac.2024.01.001_bib6","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1210\/jc.2019-00177","article-title":"Risk stratification in differentiated thyroid cancer: from detection to final follow-up","volume":"104","author":"Tuttle","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2024.01.001_bib7","doi-asserted-by":"crossref","first-page":"W867","DOI":"10.2214\/AJR.12.10370","article-title":"Current update on medullary thyroid carcinoma","volume":"201","author":"Ganeshan","year":"2013","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.eprac.2024.01.001_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/PAP.0b013e31827b6519","article-title":"Localized amyloid in thyroid: are we missing it?","volume":"20","author":"Pinto","year":"2013","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"10.1016\/j.eprac.2024.01.001_bib9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1021\/acs.molpharmaceut.1c00680","article-title":"Targeting amyloids with [18F]AV-45 for medullary thyroid carcinoma positron emission tomography\/computed tomography imaging: a pilot clinical study","volume":"19","author":"Li","year":"2022","journal-title":"Mol Pharm"},{"issue":"8","key":"10.1016\/j.eprac.2024.01.001_bib10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1515\/CCLM.1999.119","article-title":"Molecular aspects and natural source of procalcitonin","volume":"37","author":"Russwurm","year":"1999","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"10.1016\/j.eprac.2024.01.001_bib11","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1210\/en.2004-0780","article-title":"Unraveling the amyloid associated with human medullary thyroid carcinoma","volume":"145","author":"Khurana","year":"2004","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.eprac.2024.01.001_bib12","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2017-00317","article-title":"Medullary thyroid carcinoma in MEN2A: ATA moderate- or high-risk RET mutations do not predict disease aggressiveness","volume":"102","author":"Voss","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2024.01.001_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/thy.2010.0328","article-title":"Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation","volume":"21","author":"Jasim","year":"2011","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.eprac.2024.01.001_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000494675","article-title":"Unique case of a large indolent medullary thyroid carcinoma: time to reconsider the medullary thyroid adenoma entity?","volume":"8","author":"Censi","year":"2019","journal-title":"Eur Thyroid J"},{"issue":"6","key":"10.1016\/j.eprac.2024.01.001_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/thy.2009.0021","article-title":"Familial medullary thyroid carcinoma associated with cutaneous lichen amyloidosis","volume":"19","author":"Rothberg","year":"2009","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.eprac.2024.01.001_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3747\/co.26.5539","article-title":"Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines","volume":"26","author":"Thomas","year":"2019","journal-title":"Curr Oncol"},{"issue":"4","key":"10.1016\/j.eprac.2024.01.001_bib17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.eprac.2024.01.001_bib18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10120-017-0779-5","article-title":"The 8th edition of the American Joint Committee on Cancer tumor-node-metastasis staging system for gastric cancer is superior to the 7th edition: results from a Chinese mono-institutional study of 1663 patients","volume":"21","author":"Ji","year":"2018","journal-title":"Gastric Cancer"},{"issue":"4","key":"10.1016\/j.eprac.2024.01.001_bib19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.143.4.993","article-title":"Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid","volume":"143","author":"Sletten","year":"1976","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"10.1016\/j.eprac.2024.01.001_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12022-015-9390-7","article-title":"Analysis of amyloid in medullary thyroid carcinoma by mass spectrometry-based proteomic analysis","volume":"26","author":"Erickson","year":"2015","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.eprac.2024.01.001_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.747704","article-title":"Serum calcitonin-negative medullary thyroid carcinoma: a case series of 19 patients in a single center","volume":"12","author":"Kim","year":"2021","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2024.01.001_bib22","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.21037\/gs-2019-catp-21","article-title":"Updates in the advances of sporadic medullary thyroid carcinoma: from the molecules to the clinic","volume":"9","author":"Bai","year":"2020","journal-title":"Gland Surg"},{"issue":"8","key":"10.1016\/j.eprac.2024.01.001_bib23","first-page":"3803","article-title":"Procalcitonin: a new biomarker for medullary thyroid cancer? A systematic review","volume":"36","author":"Karagiannis","year":"2016","journal-title":"Anticancer Res"},{"issue":"9","key":"10.1016\/j.eprac.2024.01.001_bib24","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1038\/s41379-020-0532-1","article-title":"Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome","volume":"33","author":"Alzumaili","year":"2020","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.eprac.2024.01.001_bib25","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/PAS.0000000000001505","article-title":"A\u00a0proposed grading scheme for medullary thyroid carcinoma based on proliferative activity (Ki-67 and mitotic count) and coagulative necrosis","volume":"44","author":"Fuchs","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.eprac.2024.01.001_bib26","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/dote.12128","article-title":"Preoperative level of serum amyloid A is superior to C-reactive protein in the prognosis of esophageal squamous cell carcinoma","volume":"27","author":"Meng","year":"2014","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.eprac.2024.01.001_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1471-2407-12-365","article-title":"Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma","volume":"12","author":"Wang","year":"2012","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.eprac.2024.01.001_bib28","doi-asserted-by":"crossref","first-page":"e2300070","DOI":"10.1002\/adbi.202300070","article-title":"Inhibition of pancreatic cancer cells by different amyloid proteins reveals an inverse relationship between neurodegenerative diseases and cancer","volume":"7","author":"Tang","year":"2023","journal-title":"Adv Biol (Weinh)"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T12:59:48Z","timestamp":1729083588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X24000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1530891X24000120"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.01.001","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival Outcomes of Medullary Thyroid Cancer With and Without Amyloid Deposition","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}